The present technology relates to implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. For example, selected embodiments of the present technology comprise coil-tipped aneurysm devices that can occlude the opening at the neck of the aneurysm and inhibit dislodgement of the device relative to the aneurysm.
Many of the currently available surgical approaches for closing openings and repairing defects in anatomical lumens and tissues (e.g., blood vessels), septal defects, and other types of anatomical irregularities and defects are highly invasive. Surgical methods for clipping brain aneurysms, for example, require opening the skull, cutting or removing overlying brain tissue, clipping and repairing the aneurysm from outside the blood vessel, and then reassembling tissue and closing the skull. Surgical techniques for repairing septal defects are also highly invasive. The risks related to anesthesia, bleeding, and infection associated with these types of procedures are high, and tissue that is affected during the procedure may or may not survive and continue functioning.
Minimally invasive surgical techniques have been developed to place occlusive devices within or across an opening or cavity in the body, such as in the vasculature, spinal column, fallopian tubes, bile ducts, bronchial and other air passageways, and the like. In general, an implantable device is guided along a delivery catheter and through a distal opening of the catheter using a pusher or delivery wire to deploy the device at a target site in the vasculature. Once the occlusive device has been deployed at the target site, it is detached from the pusher mechanism without disturbing placement of the occlusive device or damaging surrounding structures.
Minimally invasive techniques are also highly desirable for treating aneurysms. In general, the minimally invasive therapeutic objective is to prevent material that collects or forms in the cavity from entering the bloodstream and to prevent blood from entering and collecting in the aneurysm. This is often accomplished by introducing various materials and devices into the aneurysm. One class of embolic agents includes injectable fluids or suspensions, such as microfibrillar collagen, various polymeric beads, and polyvinylalcohol foam. Polymeric agents may also be cross-linked to extend their stability at the vascular site. These agents are typically deposited at a target site in the vasculature using a catheter to form a solid space-filling mass. Although some of these agents provide for excellent short-term occlusion, many are thought to allow vessel recanalization due to their absorption into the blood. Other materials, such as hog hair and suspensions of metal particles, have also been proposed and used to promote occlusion of aneurysms. Polymer resins, such as cyanoacrylates, are also employed as injectable vaso-occlusive materials. These resins are typically mixed with a radiopaque contrast material or are made radiopaque by the addition of a tantalum powder. Accurate and timely placement of these mixtures is crucial and very difficult because it is difficult or impossible to control them once they have been placed in the blood flow.
Implantable vaso-occlusive metallic structures are also well known and commonly used. Many conventional vaso-occlusive devices have helical coils constructed from a shape memory material or noble metal that forms a desired coil configuration upon exiting the distal end of a delivery catheter. The function of the coil is to fill the space formed by an anatomical defect and to facilitate the formation of an embolus with the associated allied tissue. Multiple coils of the same or different structures may be implanted serially in a single aneurysm or other vessel defect during a procedure. Implantable framework structures are also used in an attempt to stabilize the wall of the aneurysm or defect prior to insertion of filling material such as coils.
Techniques for delivering conventional metallic vaso-occlusive devices to a target site generally involve a delivery catheter and a detachment mechanism that detaches the devices, such as a coil, from a delivery mechanism after placement at the target site. For example, a microcatheter can be initially steered through the delivery catheter into or adjacent to the entrance of an aneurysm either with or without a steerable guidewire. If a guidewire is used, it is then withdrawn from the microcatheter lumen and replaced by the implantable vaso-occlusive coil. The vaso-occlusive coil is advanced through and out of the microcatheter and thus deposited within the aneurysm or other vessel abnormality. It is crucial to accurately implant such vaso-occlusive devices within the internal volume of a cavity and to maintain the device within the internal volume of the aneurysm. Migration or projection of a vaso-occlusive device from the cavity may interfere with blood flow or nearby physiological structures and poses a serious health risk.
In addition to the difficulties of delivering implantable occlusion devices, some types of aneurysms are challenging to treat because of structural features of the aneurysm or because of particularities of the site. Wide-neck aneurysms, for example, are known to present particular difficulty in the placement and retention of vaso-occlusive coils. Aneurysms at sites of vascular bifurcation are another example where the anatomical structure poses challenges to methods and devices that are effective in treating the typical sidewall aneurysms.
In view of such challenges, implanting conventional embolic coils, other structures, or materials in the internal space of an aneurysm has not been an entirely satisfactory surgical approach. The placement procedure may be arduous and lengthy because it often requires implanting multiple devices, such as coils, serially in the internal space of the aneurysm. Higher risks of complication from such sources as anesthesia, bleeding, thromboembolic events, procedural stroke, and infection are associated with such longer procedures. Moreover, because placement of structures in the internal space of an aneurysm does not generally completely occlude the opening, recanalization of the original aneurysm may occur, and debris and occlusive material may escape from within the aneurysm to create a risk of stroke or vessel blockage. Blood may also flow into the aneurysm after the placement of embolic devices, which may increase the risks of complication and further enlargement of the aneurysm.
Despite the numerous conventional devices and systems available for implanting embolic materials in an aneurysm and for occluding physiological defects using minimally invasive techniques, these procedures remain risky and rarely restore the physiological structure to its normal, healthy condition. It is also challenging to position conventional implantable devices during deployment, prevent shifting or migration of such devices after deployment, and preserve blood flow in neighboring vessels following after deployment.
The present disclosure describes implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. In particular, selected embodiments of the present technology comprise a coil loop, or tip, on a portion of the implantable device. The coil tip can provide a soft and/or smooth interface with the aneurysm and can provide improved coverage of the neck of the aneurysm. The following description provides many specific details for a thorough understanding of, and enabling description for, embodiments of the disclosure. Well-known structures, systems, and methods often associated with such systems have not been shown or described in detail to avoid unnecessarily obscuring the description of the various embodiments of the disclosure. In addition, those of ordinary skill in the relevant art will understand that additional embodiments may be practiced without several of the details described below.
The closure structure 152 can be a frame, scaffold, or other structure that can at least partially occlude, span, or block the neck of an aneurysm to prevent embolic coils or other coagulative material within the aneurysm from escaping into the bloodstream. The proximally-extending sides of the closure structure 152 and the supplemental stabilizer 153 hold a curved portion of the closure structure 152 at the neck of the aneurysm. The closure structure 152 includes a perimeter support 160 and an inner support 170. The supports 160 and 170 can have a rhombus-like (e.g., diamond-shaped) shape or configuration. The perimeter support 160 and inner support 170 can be joined at junctions 162 and 164. The aneurysm device 150 can also have struts 180a-d projecting proximally from the junctions 162 and 164. Struts 180a-b are connected at junction 162 and struts 180c-d are connected at junction 164 to form the supplemental stabilizer 153 with proximal anchoring segments.
The coil tips 101 can be coupled to the closure structure 152 and/or the supplemental stabilizer 153. In the illustrated embodiment, for example, the coil tips 101 are coupled to the junctions 162 and 164 (e.g., by soldering or other attachment mechanism). In further embodiments, the coil tips 101 may be co-formed with the closure structure 152 and/or supplemental stabilizer 153. In several embodiments, the coil tips 101 extend peripherally and/or distally beyond the perimeter supports 160. In some embodiments, the coil tips 101 replace the perimeter supports 160. The coil tips 101 can comprise various biocompatible materials, such as biocompatible metal or plastic. In one particular embodiment, for example, the coil tips 101 comprise a platinum coil having a 0.005 inch outside diameter. In further embodiments, the coil tips 101 can comprise different materials or sizes. In several embodiments, the coil tips 101 can be a soft and/or smooth shape or material to easily interface with an aneurysm.
While
In multiple device embodiments, the aneurysm device 150 is deployed such that it is anchored along a specific portion of an aneurysm neck. For example,
The coil tips 101 can extend distally and/or peripherally along or into the aneurysm and can improve the aneurysm device's ability to provide aneurysm neck coverage, as the coil tip 101 can be configured to be placed inside the aneurysm. For example, the coil tips 101 can be curved (e.g., complex curved) or parabolic shaped to better conform to the shape of the aneurysm or the vasculature to provide the desired degree of aneurysm occlusion and device stability. In the illustrated embodiment, the coil tips 101 can be placed within the aneurysm and can conform against the aneurysm wall, while the rest of the closure structure 152 (i.e., the inner supports 170 and perimeter supports 160) can conform against the luminal wall outside of the aneurysm. In some embodiments, the coil tips 101 contained in the aneurysm reside in the neck portion of the aneurysm and do not significantly or at all protrude past the neck portion into a body portion of the aneurysm. In still further embodiments, the coil tips 101 extend into the body of the aneurysm but do not conform to the aneurysm walls. In other embodiments, the coil tips 101 can conform against the luminal wall outside of the aneurysm.
The closure structure 152 can bridge a portion or all of the aneurysm neck and control blood flow into the aneurysm. In several embodiments, for example, the closure structure 152 spans unobtrusively over the lumina of the bifurcating arteries, forming no incursion into the vascular flow path. More particularly, the closure structure 152 can form a non-enclosed opening or hole, and in some embodiments can be entirely open in the proximal direction. In some embodiments, the coil tips 101 at least partially block or are positioned in the neck portion of the aneurysm A without causing significant stasis of flow in the aneurysm A.
The optional supplemental stabilizer 153 extends proximally from the closure structure 152 at an angle relative to a lateral axis. The supplemental stabilizer 153 can have struts that extend down into the parent artery and press outwardly against the luminal surface thereof. In further embodiments, the supplemental stabilizer 153 is absent.
The following Examples are illustrative of several embodiments of the present technology.
1. An aneurysm device endovascularly deliverable to a site proximate to an aneurysm in an artery, the aneurysm device comprising:
2. The aneurysm device of example 1 wherein the coil tip comprises a loop shape, a basket shape, or a coil shape.
3. The aneurysm device of example 1 wherein the coil tip comprises platinum.
4. The aneurysm device of example 1, further comprising an attachment feature configured to couple the coil tip to the closure structure.
5. The aneurysm device of example 4 wherein the attachment feature comprises hardened solder.
6. The aneurysm device of example 1 wherein a portion of at least one of the closure structure or coil tip is at least partially covered with a barrier configured to occlude at least a portion of the aneurysm
7. The aneurysm device of example 1 wherein the coil tip resides in a neck portion of the aneurysm.
8. The aneurysm device of example 1 wherein the coil tip comprises a permeable framework configured to allow flow to or from the aneurysm.
9. The aneurysm device of example 1, further comprising a supplemental stabilizer proximally connected to the closure structure, wherein the supplemental stabilizer is configured to reside in the artery and press outward against a luminal wall thereof.
10. The aneurysm device of example 1 wherein the coil tip comprises a first coil tip, and wherein the device further comprises a second coil tip extending from the closure structure, and wherein the first coil tip and second coil tip extend peripherally from opposing lateral sides of the closure structure.
11. The aneurysm device of example 10 wherein the first coil tip and second coil tip each comprise a loop and together form a generally Figure-8 shape.
12. The aneurysm device of example 1 wherein the closure structure comprises a plurality of laterally opposing supports.
13. The aneurysm device of example 1 wherein at least one of the distal-facing aspect of the closure structure or the coil tip form a complex curved surface.
14. An aneurysm device endovascularly deliverable to a site proximate to an aneurysm, the aneurysm device comprising:
15. The aneurysm device of example 14 wherein the coil tips each comprise a loop shape, a basket shape, or a coil shape.
16. The aneurysm device of example 14 wherein the coil tips reside in a neck portion of the aneurysm.
17. The aneurysm device of example 14 wherein the closure structure and coil tips comprise a permeable framework configured to allow flow to or from the aneurysm.
18. An aneurysm enclosure framework endovascularly deliverable to a site proximate to an aneurysm, the framework, when expanded at the site, comprising:
19. The aneurysm device of example 18 wherein the first coil tip and second coil tip each comprise a loop and together form a generally Figure-8 shape.
20. The aneurysm device of example 18 wherein the first coil tip and second coil tip press or contour against at least one of a neck portion or wall portion of the aneurysm.
From the foregoing, it will be appreciated that specific embodiments of the disclosure have been described herein for purposes of illustration, but that various modifications may be made without deviating from the spirit and scope of the disclosure. For example, structures and/or processes described in the context of particular embodiments may be combined or eliminated in other embodiments. In particular, the aneurysm devices described above with reference to particular embodiments can include one or more additional features or components, or one or more of the features described above can be omitted. Further, the coil tips described herein may be employed with a variety of different aneurysm devices or assemblies in addition to those described above. Moreover, while advantages associated with certain embodiments of the disclosure have been described in the context of these embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the disclosure.
The present application claims the benefit of and priority to U.S. Provisional Patent Application No. 61/645,496, filed May 10, 2012, which is incorporated herein by reference in its entirety. Further, components and features of embodiments disclosed in the application incorporated by reference may be combined with various components and features disclosed and claimed in the present application.
Number | Name | Date | Kind |
---|---|---|---|
3868956 | Alfidi et al. | Mar 1975 | A |
4164045 | Bokros et al. | Aug 1979 | A |
4248234 | Assenza et al. | Feb 1981 | A |
4645495 | Vaillancourt | Feb 1987 | A |
4651751 | Swendson et al. | Mar 1987 | A |
4665906 | Jervis | May 1987 | A |
4706671 | Weinrib | Nov 1987 | A |
4710192 | Liotta et al. | Dec 1987 | A |
4739768 | Engelson | Apr 1988 | A |
4820298 | Leveen et al. | Apr 1989 | A |
4873978 | Ginsburg | Oct 1989 | A |
4909787 | Danforth | Mar 1990 | A |
4994069 | Ritchart et al. | Feb 1991 | A |
5011488 | Ginsburg | Apr 1991 | A |
5074869 | Daicoff | Dec 1991 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5226911 | Chee et al. | Jul 1993 | A |
5250071 | Palermo | Oct 1993 | A |
5261916 | Engelson | Nov 1993 | A |
5263964 | Purdy | Nov 1993 | A |
5263974 | Matsutani et al. | Nov 1993 | A |
5271414 | Partika et al. | Dec 1993 | A |
5304195 | Twyford, Jr. et al. | Apr 1994 | A |
5334168 | Hemmer | Aug 1994 | A |
5342386 | Trotta | Aug 1994 | A |
5350397 | Palermo et al. | Sep 1994 | A |
5354295 | Guglielmi et al. | Oct 1994 | A |
5527338 | Purdy | Jun 1996 | A |
5531685 | Hemmer et al. | Jul 1996 | A |
5578074 | Mirigian | Nov 1996 | A |
5624449 | Pham et al. | Apr 1997 | A |
5643254 | Scheldrup et al. | Jul 1997 | A |
5665106 | Hammerslag | Sep 1997 | A |
5669931 | Kupiecki et al. | Sep 1997 | A |
5693067 | Purdy | Dec 1997 | A |
5733294 | Forber et al. | Mar 1998 | A |
5733329 | Wallace et al. | Mar 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5749894 | Engelson | May 1998 | A |
5759194 | Hammerslag | Jun 1998 | A |
5766192 | Zacca | Jun 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5797953 | Tekulve | Aug 1998 | A |
5814062 | Sepetka et al. | Sep 1998 | A |
5843103 | Wulfman | Dec 1998 | A |
D407818 | Mariant et al. | Apr 1999 | S |
5895391 | Farnholtz | Apr 1999 | A |
5895410 | Forber et al. | Apr 1999 | A |
5910145 | Fischell et al. | Jun 1999 | A |
5911737 | Lee et al. | Jun 1999 | A |
5916235 | Guglielmi | Jun 1999 | A |
5925060 | Forber | Jul 1999 | A |
5925062 | Purdy | Jul 1999 | A |
5925683 | Park | Jul 1999 | A |
5928260 | Chin et al. | Jul 1999 | A |
5933329 | Tijanoc et al. | Aug 1999 | A |
5935114 | Jang et al. | Aug 1999 | A |
5935148 | Villar et al. | Aug 1999 | A |
5951599 | McCrory | Sep 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
5980514 | Kupiecki et al. | Nov 1999 | A |
5984944 | Forber | Nov 1999 | A |
6007544 | Kim | Dec 1999 | A |
6013055 | Bampos et al. | Jan 2000 | A |
6022341 | Lentz | Feb 2000 | A |
6036720 | Abrams et al. | Mar 2000 | A |
6063070 | Eder | May 2000 | A |
6063104 | Villar et al. | May 2000 | A |
6071263 | Kirkman | Jun 2000 | A |
6077291 | Das | Jun 2000 | A |
6081263 | LeGall et al. | Jun 2000 | A |
6090125 | Horton | Jul 2000 | A |
6093199 | Brown et al. | Jul 2000 | A |
6096021 | Helm et al. | Aug 2000 | A |
6096034 | Kupiecki et al. | Aug 2000 | A |
6102917 | Maitland et al. | Aug 2000 | A |
6110191 | Dehdashtian et al. | Aug 2000 | A |
6117157 | Tekulve | Sep 2000 | A |
6139564 | Teoh | Oct 2000 | A |
6146339 | Biagtan et al. | Nov 2000 | A |
6152944 | Holman et al. | Nov 2000 | A |
6168615 | Ken et al. | Jan 2001 | B1 |
6168622 | Mazzocchi | Jan 2001 | B1 |
6174322 | Schneidt | Jan 2001 | B1 |
6183495 | Lenker et al. | Feb 2001 | B1 |
6193708 | Ken et al. | Feb 2001 | B1 |
RE37117 | Palermo | Mar 2001 | E |
6221066 | Ferrera et al. | Apr 2001 | B1 |
6221086 | Forber | Apr 2001 | B1 |
6224610 | Ferrera | May 2001 | B1 |
6228052 | Pohndorf | May 2001 | B1 |
6261305 | Marotta et al. | Jul 2001 | B1 |
6293960 | Ken | Sep 2001 | B1 |
6296622 | Kurz et al. | Oct 2001 | B1 |
6309367 | Boock | Oct 2001 | B1 |
6325807 | Que | Dec 2001 | B1 |
6344048 | Chin et al. | Feb 2002 | B1 |
6375668 | Gifford et al. | Apr 2002 | B1 |
6383174 | Eder | May 2002 | B1 |
6398791 | Que et al. | Jun 2002 | B1 |
6478773 | Gandhi et al. | Nov 2002 | B1 |
6491711 | Durcan | Dec 2002 | B1 |
6517515 | Eidenschink | Feb 2003 | B1 |
6530935 | Wensel et al. | Mar 2003 | B2 |
6533905 | Johnson et al. | Mar 2003 | B2 |
6554794 | Mueller et al. | Apr 2003 | B1 |
6589256 | Forber | Jul 2003 | B2 |
6613074 | Mitelberg et al. | Sep 2003 | B1 |
6616681 | Hanson et al. | Sep 2003 | B2 |
6626889 | Simpson et al. | Sep 2003 | B1 |
6626928 | Raymond et al. | Sep 2003 | B1 |
6638268 | Niazi | Oct 2003 | B2 |
6652556 | VanTassel et al. | Nov 2003 | B1 |
6663607 | Slaikeu et al. | Dec 2003 | B2 |
6663648 | Trotta | Dec 2003 | B1 |
6669795 | Johnson et al. | Dec 2003 | B2 |
6672338 | Esashi et al. | Jan 2004 | B1 |
6679836 | Couvillon, Jr. | Jan 2004 | B2 |
6679903 | Kurz | Jan 2004 | B2 |
6689141 | Ferrera et al. | Feb 2004 | B2 |
6694979 | Deem et al. | Feb 2004 | B2 |
6723112 | Ho et al. | Apr 2004 | B2 |
6740073 | Saville | May 2004 | B1 |
6740277 | Howell et al. | May 2004 | B2 |
6746468 | Sepetka et al. | Jun 2004 | B1 |
6780196 | Chin et al. | Aug 2004 | B2 |
6790218 | Jayaraman | Sep 2004 | B2 |
6824553 | Samson et al. | Nov 2004 | B1 |
6835185 | Ramzipoor et al. | Dec 2004 | B2 |
6837870 | Duchamp | Jan 2005 | B2 |
6863678 | Lee et al. | Mar 2005 | B2 |
6890218 | Patwardhan et al. | May 2005 | B2 |
6911037 | Gainor et al. | Jun 2005 | B2 |
6936055 | Ken et al. | Aug 2005 | B1 |
6939055 | Durrant et al. | Sep 2005 | B2 |
6986774 | Middleman et al. | Jan 2006 | B2 |
6994092 | van der Burg et al. | Feb 2006 | B2 |
7011094 | Rapacki et al. | Mar 2006 | B2 |
7033374 | Schaefer et al. | Apr 2006 | B2 |
7033387 | Zadno-Azizi et al. | Apr 2006 | B2 |
7122043 | Greenhalgh et al. | Oct 2006 | B2 |
7147659 | Jones | Dec 2006 | B2 |
7156871 | Jones et al. | Jan 2007 | B2 |
7229461 | Chin et al. | Jun 2007 | B2 |
7232461 | Ramer | Jun 2007 | B2 |
7267679 | McGuckin, Jr. et al. | Sep 2007 | B2 |
7322960 | Yamamoto et al. | Jan 2008 | B2 |
7343856 | Blohdorn | Mar 2008 | B2 |
7387629 | Vanney et al. | Jun 2008 | B2 |
7410482 | Murphy et al. | Aug 2008 | B2 |
7569066 | Gerberding et al. | Aug 2009 | B2 |
7608088 | Jones et al. | Oct 2009 | B2 |
7662168 | McGuckin, Jr. et al. | Feb 2010 | B2 |
7857825 | Moran et al. | Dec 2010 | B2 |
7892254 | Klint et al. | Feb 2011 | B2 |
8075585 | Lee et al. | Dec 2011 | B2 |
8388650 | Gerberding et al. | Mar 2013 | B2 |
20030057156 | Peterson et al. | Mar 2003 | A1 |
20030139802 | Wulfman et al. | Jul 2003 | A1 |
20030181922 | Alferness | Sep 2003 | A1 |
20030181942 | Sutton et al. | Sep 2003 | A1 |
20030195385 | DeVore | Oct 2003 | A1 |
20030195553 | Wallace et al. | Oct 2003 | A1 |
20030212412 | Dillard et al. | Nov 2003 | A1 |
20040068314 | Jones et al. | Apr 2004 | A1 |
20040087998 | Lee et al. | May 2004 | A1 |
20040111112 | Hoffmann | Jun 2004 | A1 |
20040167597 | Costantino et al. | Aug 2004 | A1 |
20040167602 | Fischell et al. | Aug 2004 | A1 |
20040193246 | Ferrera | Sep 2004 | A1 |
20040210248 | Gordon et al. | Oct 2004 | A1 |
20040210298 | Rabkin et al. | Oct 2004 | A1 |
20050021023 | Guglielmi et al. | Jan 2005 | A1 |
20050025797 | Wang et al. | Feb 2005 | A1 |
20050096728 | Ramer | May 2005 | A1 |
20050177224 | Fogarty et al. | Aug 2005 | A1 |
20060030929 | Musbach | Feb 2006 | A1 |
20060052862 | Kanamaru et al. | Mar 2006 | A1 |
20060058837 | Bose et al. | Mar 2006 | A1 |
20060106418 | Seibold et al. | May 2006 | A1 |
20060247680 | Amplatz et al. | Nov 2006 | A1 |
20060259131 | Molaei et al. | Nov 2006 | A1 |
20060264905 | Eskridge et al. | Nov 2006 | A1 |
20060264907 | Eskridge et al. | Nov 2006 | A1 |
20070067015 | Jones et al. | Mar 2007 | A1 |
20070088387 | Eskridge et al. | Apr 2007 | A1 |
20070106311 | Wallace et al. | May 2007 | A1 |
20070191884 | Eskridge et al. | Aug 2007 | A1 |
20070270902 | Slazas et al. | Nov 2007 | A1 |
20080039930 | Jones et al. | Feb 2008 | A1 |
20080147100 | Wallace | Jun 2008 | A1 |
20080183143 | Palisis et al. | Jul 2008 | A1 |
20080221600 | Dieck et al. | Sep 2008 | A1 |
20080269774 | Garcia et al. | Oct 2008 | A1 |
20090306678 | Hardert et al. | Dec 2009 | A1 |
20100094335 | Gerberding et al. | Apr 2010 | A1 |
20130090682 | Bachman et al. | Apr 2013 | A1 |
20130204290 | Clarke et al. | Aug 2013 | A1 |
20130268046 | Gerberding et al. | Oct 2013 | A1 |
Number | Date | Country |
---|---|---|
2006304660 | Apr 2007 | AU |
1399530 | Feb 2003 | CN |
101489492 | Jul 2009 | CN |
102202585 | Sep 2011 | CN |
102762156 | Oct 2012 | CN |
103230290 | Aug 2013 | CN |
103381101 | Nov 2013 | CN |
103582460 | Feb 2014 | CN |
103607964 | Feb 2014 | CN |
102008028308 | Apr 2009 | DE |
0820726 | Jan 1998 | EP |
00996372 | May 2000 | EP |
1269935 | Jan 2003 | EP |
1527753 | May 2005 | EP |
1951129 | Aug 2008 | EP |
2326259 | Jun 2011 | EP |
2451363 | May 2012 | EP |
2713904 | Apr 2014 | EP |
2713905 | Apr 2014 | EP |
1134421 | Mar 2014 | HK |
2001286478 | Oct 2001 | JP |
2009512515 | Mar 2009 | JP |
2013226419 | Nov 2013 | JP |
20080081899 | Sep 2008 | KR |
WO-9724978 | Jul 1997 | WO |
WO-9726939 | Jul 1997 | WO |
WO-9731672 | Sep 1997 | WO |
WO-9823227 | Jun 1998 | WO |
WO-9850102 | Nov 1998 | WO |
WO-9905977 | Feb 1999 | WO |
WO-9907294 | Feb 1999 | WO |
WO-9915225 | Apr 1999 | WO |
WO-0013593 | Mar 2000 | WO |
WO-0130266 | May 2001 | WO |
WO0200139 | Jan 2002 | WO |
WO-0213899 | Feb 2002 | WO |
WO-02071977 | Sep 2002 | WO |
WO-02078777 | Oct 2002 | WO |
WO-02087690 | Nov 2002 | WO |
WO-03059176 | Jul 2003 | WO |
WO-03075793 | Sep 2003 | WO |
WO-2004019790 | Mar 2004 | WO |
WO-2004026149 | Apr 2004 | WO |
WO-2004105599 | Dec 2004 | WO |
WO-2005033409 | Apr 2005 | WO |
WO-2005082279 | Sep 2005 | WO |
WO-2006119422 | Nov 2006 | WO |
WO-2007047851 | Apr 2007 | WO |
WO-2008151204 | Dec 2008 | WO |
WO-2010028314 | Mar 2010 | WO |
WO-2011029063 | Mar 2011 | WO |
WO-2012167137 | Dec 2012 | WO |
WO-2012167150 | Dec 2012 | WO |
WO-2012167156 | Dec 2012 | WO |
WO-2013052920 | Apr 2013 | WO |
Entry |
---|
Cordis NeuroVascular, Inc.; “Masstransit Microcatheter,” Product Prochure; No. 153-8383-3; Miami Lakes, FL, USA (2003). |
Cordis NeuroVascular, Inc.; “Prolwer Select Plus Microcatheter,” Product Brochure; No. 154-9877-1; Miami Lakes, FL, USA (2003). |
Cordis NeuroVascular, Inc.; “Prowler Select LP Microcatheter,” Product Brochure; No. 155-5585; Miami Lakes, FL, USA (2004). |
Cordis NeuroVascular, Inc.; “Rapid Transit Microcatheter,” Product Brochure; No. 152-7369-2; Miami Lakes, FL, USA (2003). |
Extended European Search Report, European Application No. 06826291.4, Nov. 19, 2009, 7 pages. |
Gupta et al. SMST-2003: Proc. Intl. Conf. Shape Memory Superelastic Technol.; Pacific Grove, CA; p. 639; 2003. |
International Search Report and Written Opinion for Application No. PCT/US2010/047908, Mail Date May 25, 2011. |
International Search Report and Written Opinion for International Application No. PCT/US2009/056133, Mail Date Oct. 26, 2009, 11 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2010/047908, mailing date Mar. 15, 2012, 11 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2012/040552, mailing date Aug. 28, 2012, 14 pages. |
International Search Report and Written Opinion for International Application PCT/US2012/040536, mailing date Oct. 15, 2012, 17 pages. |
International Search Report and Written Opinion for International Application PCT/US2012/040558, mailing date Oct. 8, 2012, 17 pages. |
International Search Report and Written Opinion for International Application PCT/US2012/059133, mailing date Mar. 11, 2013,15 pages. |
International Search Report and Written Opinion for International Application PCT/US2013/031793, mailing date Jun. 26, 2013, 14 pages. |
International Search Report for International Application No. PCT/US06/40907, Mail Date May 1, 2008, 2 pages. |
Micrus Copr.; “Concourse 14 Microcatheter” Product Brochure; Sunnyvale ,CA, USA. |
Polytetraflouroethylene Implants, DermNet NZ, Nov. 11, 2005, http://dermetnz.org/polytetrafluoroethylene.html. |
Singapore Examination Report for Singapore Application No. 200802811-0, Mail Date Jul. 12, 2009, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20130304109 A1 | Nov 2013 | US |
Number | Date | Country | |
---|---|---|---|
61645496 | May 2012 | US |